LCN2 and chronic kidney disease: In the present study, we observed a significant association between higher levels of plasma NGAL and reduced eGFR at baseline and, prospectively, we observed higher plasma NGAL levels in individuals having a higher risk of developing new-onset CKD (as (partially) defined by eGFR).